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OBJECTIVES 
 The focus of interest of our group is the study of different 
microbiological issues related to antimicrobial resistance in 
gram-negative bacteria in our geographical area.  
ANTIBIOTIC RESISTANCE: AN EMERGING PROBLEM 
 One of the most pressing causes of health concern from 
individual (clinical), ecological (public health) and social 
perspective, aggravated by the lack of new antimicrobials 
development.  
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 Emergence of antibiotic resistance is an inevitable 
consequence of antimicrobials use in any setting 
(humans, animals, agriculture). 
12 Steps to Prevent Antimicrobial 
Resistance: Hospitalized Adults 
   12      Break the chain 
              11   Isolate the pathogen 
           10 Stop treatment when cured 
       9   Know when to say “no” to vanco 
   8  Treat infection, not colonization 
              7  Treat infection, not contamination 
           6  
       5  Practice antimicrobial control 
    4  Access the experts 
              3 Target the pathogen 
           2  Get the catheters out 
       1  Vaccinate 
 




Use Antimicrobials Wisely 
 
Diagnose & Treat Effectively 
Prevent Infections 
Campaign to Prevent Antimicrobial Resistance in Healthcare Settings 
INVESTIGATION LINES  
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 Characterization of mechanisms involved in antimicrobial 
resistance in gram-negative bacteria.  
  Particularly resistance to β-lactams (amoxicillin-clavulanate) 
and Integron-associated resistance.  
 Optimization of antibiotic therapy: improvement in 
effectiveness and prevention of emergence of resistances.  
 
 Molecular epidemiology studies of isolates displaying 
troublesome or uncommon resistance mechanisms aimed at 
establishing the reasons for their spread and designing 
strategies to bring it under control 
 Horizontal transfer of genetic resistance elements (antibiotic policy)  
 Spread of a limited number of clones (infection control measures) 
INTEGRONS 
 Integrons   
● widespread, potentially mobile, rather small, genetic elements.  
● generally located on plasmids or transposons.  
● able to incorporate and mobilize resistance gene cassettes throughout a 
site-specific recombination system directed by an integrase.  
 Class 1 integrons are the commonest. 
 Two highly conserved regions (5’CS and 3’CS ends) flanking a variable region 










 Important and efficient (low biological cost) source for the acquisition, and 
spread of resistance and cross-resistance in gram-negative bacteria.  
Promotor 
PROJECTS (I)  
 Characterization of mechanisms involved in 
resistance to associations of B-lactams plus -
lactamase inhibitors in Escherichia coli isolates 
recovered in Terres de l’Ebre 
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METHODS: Isoelectrophocusing  
(characterization of β-lactamases 
according to pI) and  
spectophotometry (β-lactamase 
















 A number of mechanisms responsible 
for resistance to amoxicillin-
clavulanate in Escherichia coli  
● TEM-1 hyperproduction 
● AMPc hyperproduction or plasmidic 
cephamycinases. 
● IRT β-lactamases production  
● OXA-1 production  
 
 Only one previous surveillance 
study in Spain to know the 
prevalence of IRT enzymes in E. 
coli (specific resistance 
mechanism against β-lactamase 
inhibitors).  
● Mechanism difficult to recognize 
by conventional antibiogram. 
● Inclusion of low concentrations of 
cefepime in microdilution panels 
is a helpful tool for distinguishing 
OXA-1 from IRT B-lactamases.   
● Low but on the increase 
prevalence specially in 
community acquired UTI (related 










 Molecular epidemiology and characterization of 
resistance mechanisms involved in reduced 
susceptibility to amoxicillin-clavulanate in Klebsiella 
pneumoniae isolates from a chronic-care center. 
  
 Striking rate of decreased susceptibility to amoxicillin-clavulanate among 
cephalosporin-susceptible K. pneumoniae isolates recovered from patients 
from a chronic-care hospital, where amoxicillin-clavulanate was the most 









 PCR amplification or PCR-mapping 
assays and nucleotide sequencing:  
 tracking of genes encoding β-lactamases and 
other antibiotic resistance determinants,  
 chromosomal mutations in gyrA and parC  
 presence of class 1 integrons and 
identification of resistance cassettes within 
the integron variable region. 
 ERIC-PCR: DNA fingerprinting to assess 
epidemiological relationship between 
isolates.  
 Conjugation experiments:  To ascertain 
the eventual location of resistance 






RESULTS (II)  
 
 Mechanisms involved: Coexistence of isolates displaying two different -
lactamases, quite uncommon in this species, conferring specific resistance to β-
lactamase inhibitors (IRT-11and OXA-1 -lactamase).  
 
 In almost all cases gene encoding OXA-1 located within a class 1 integron 
together with other antibiotic resistance determinants (aminoglycosides,  
quinolones, chloramphenicol and rifampicin) and associated to qnrS2 
(transferible resistance to quinolones) in a conjugative plasmid (Estructure only 




 An identical integron, although in a different genetic environment – associated 
to genes encoding plasmidic cephamycinases - has been described in some 
sporadic human Enterobacterial isolates. 
 
 Three isolates carried an atypical class 1 integron lacking qacE1 and sul 
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 ERIC-PCR Patterns 
Lanes 1-5 and 7-8: OXA-1 producing isolates 
Lanes 9-11: IRT-11 producing isolates 
Lane 6: amoxicillin/clavulanate-susceptible isolate 
  IRT-11 producing isolates 
ascribed to three clones (E1 to E3) 
 Clonal dissemination and 
horizontal transfer. 
 
 OXA-1 producing isolates carrying 
typical class integron ascribed to  
two closely related clones (E3 and 
E3a)  Clonal dissemination.  
 
 OXA-1 producing isolates carrying 
defective class 1 integron ascribed 
to one clone (E4)  Clonal 
dissemination.  
 
But in 2009 two qnrS2 Escherichia coli 
isolates harbouring the same atypical 
integron. 
 
RESULTS (II)  
CONCLUSIONS (II) 
 Second description reporting an outbreak involving IRT 
enzymes (the first one occurred in a chronic-care facility in 
France). 
 Importance of diversifying antibiotics used in an institution in 
order to avoid selective pressure which favours emergence of 
resistances.  
• High consumption of ACL in the hospital lead to the emergence and 
selection of a resistance mechanism typical of community-acquired 
isolates.  
 Outstanding: adherence to standard infection control 
precautions. 
• Cross-infection between patients lead to dissemination of resistant 
clones. 
 Role played by integrons in co-selection (use of a single 
antimicrobial may select for resistance to other antibiotics) 







 Role of integrons in antibiotic resistance in a 
typical zoonotic community-acquired 
infection: Food-borne disease caused by Non-




RESULTS (III)  
 Class 1 integron dissemination among multiresistant 
Salmonella enterica human isolates from Terres de l’Ebre 
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RESULTS (III)  
 Molecular epidemiology of infections  caused by 
multiresistant integron-carrying human Salmonella 
enterica serotype Typhimurium isolates from the health 
Region of Terres de l’Ebre 
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Figura 3: Freqüència de resistència als  diferents antimicrobians 
Total (n=522) Aïllats amb integrons (n=140) Aïllats sense integrons (n=382)
 
 Multiresistance linked to integrons is 
widespread among human Salmonella 
enterica  isolates from our geographical 
region  
● 59% of MR isolates carried integrons. 
● 10 different types of integrons in 14 
different serotypes of Salmonella. 
 
 Resistance genes born by or linked to 
integrons  usually confer resistance to 
antibiotics employed in livestock and 
veterinary medicine but also to some 
that are the first choice in treatment of 
systemic human salmonellosis 
(amoxicillin-clavulanate, broad-range 
cephalosporins).   
● Need of wise antibiotic use in animals: 
selective pressure posed by antibiotic use 
in food animals may have negative impact 






•bla oxa-1 –aadA1 
•aadA2/ bla pse-1  
RESULTS AND CONCLUSIONS (III) 
 Dramatic increase in the prevalence of serotype Typhimurium, usually more 
resistant and in some cases more virulent, to the detriment of serotype 
Enteritidis.  
● Efforts to minimize the transmission of all food-borne pathogens by insistence on 
good hygiene practices on farms, in abattoirs, during distribution and marketing of 
food and in food preparation.  
 
 First description of 
● The presence of integrons in some unusual serotypes (Kapemba,  Goettingen  
and S. Sub. I [9,12: lv:-] 
● The emergence of S. enterica isolates harbouring atypical sul3-associated 
integrons, not previously reported in Spain,  that are not detected by 
conventional methods.  
● The emergence of S. Typhimurium isolates possessing a particular plasmid-
borne integron (2 Kb/ bla oxa-1 –aadA1) which nowadays have became endemic in 
Spain and have  displaced the pandemic SGI1 isolates. 
● Most isolates of both types belonged to a predominant clone and shared the 
same resistance phenotype except for resistance to nitrofurantoin (related with 




 Going on with surveillance of local antimicrobial resistance 
 and underlying mechanisms and 
 epidemiology 
● Follow of resistance trends 
● Alert for new resistance mechanisms  
● Identify risk factors for antimicrobial  
     resistance  
● Design and evaluate interventions to 
    control antimicrobial resistance 
 Extending the scope of our research on resistance 
mechanisms 
● Transferable quinolone resistance 
● Characterization of an SHV-derived β-lactamase conferring an atypical 
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